Detalles de la búsqueda
1.
Evaluation of the inflammatory parameters as potential biomarkers of systemic inflammation extent and the disease severity in psoriasis patients.
Arch Dermatol Res;
316(6): 229, 2024 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38787405
2.
Unmet Needs and Treatment Preference of Systemic Treatments for Moderate-to-Severe Psoriasis from the Perspectives of Patients and Dermatologists in China.
Dermatol Ther (Heidelb);
14(5): 1245-1257, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38733512
3.
Rapid and sustained resolution in generalized pustular psoriasis with IL-17A inhibitors required high adherence: a 96-week analysis in a real-life setting.
Int J Dermatol;
2024 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38632699
4.
Short-term effectiveness and potential factors of ustekinumab based on real-world data in Chinese psoriasis patients.
J Dermatolog Treat;
35(1): 2321188, 2024 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38531383
5.
Comparison between super-responders and non-super-responders in psoriasis under adalimumab treatment: a real-life cohort study on the effectiveness and drug survival over one-year.
J Dermatolog Treat;
35(1): 2331782, 2024 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38513258
6.
Defining the Minimal Important Change and Meaningful Change Value of the Disease Activity Index for Psoriatic Arthritis: A Chinese Longitudinal Study.
J Rheumatol;
2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38490673
7.
A BET inhibitor, NHWD-870, can downregulate dendritic cells maturation via the IRF7-mediated signaling pathway to ameliorate imiquimod-induced psoriasis-like murine skin inflammation.
Eur J Pharmacol;
968: 176382, 2024 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38311277
8.
The CD147 expression in CD4+ T cells is a novel biomarker for predicting efficacy of IL-17A inhibitor and psoriasis recurrence.
Clin Transl Med;
14(2): e1568, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38303607
9.
The impacts of biologic treatment on metabolic profiling in psoriasis.
Exp Dermatol;
33(1): e15011, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38284208
10.
Altered brain activity and cognitive impairment in patients with psoriasis.
J Eur Acad Dermatol Venereol;
38(3): 557-567, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38059666
11.
[Corrigendum] Downregulation of CD147 induces malignant melanoma cell apoptosis via the regulation of IGFBP2 expression.
Int J Oncol;
64(1)2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37997849
12.
Age at Natural Menopause, Reproductive Lifespan, and the Risk of Late-Onset Psoriasis and Psoriatic Arthritis in Women: A Prospective Cohort Study.
J Invest Dermatol;
2023 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38081449
13.
Adenosine 5'monophosphate-activated protein kinase activation reduces the risks of psoriasis and its comorbidities: a mendelian randomisation study in the UK Biobank.
Rheumatology (Oxford);
2023 Sep 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37672020
14.
Schulungsangebot korreliert mit stärkerer Verbesserung und höherer Adhärenz bei Psoriasis-Patienten, die auf Ixekizumab ansprechen.
J Dtsch Dermatol Ges;
21(8): 900-903, 2023 08.
Artículo
en Alemán
| MEDLINE | ID: mdl-37574673
15.
Educational service correlates with greater improvement and adherence in psoriasis patients responding to ixekizumab.
J Dtsch Dermatol Ges;
21(8): 900-902, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37480160
16.
CD147 Facilitates the Pathogenesis of Psoriasis through Glycolysis and H3K9me3 Modification in Keratinocytes.
Research (Wash D C);
6: 0167, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37303600
17.
NHWD-1062 ameliorates inflammation and proliferation by the RIPK1/NF-κB/TLR1 axis in Psoriatic Keratinocytes.
Biomed Pharmacother;
162: 114638, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37011486
18.
Lysophosphatidylcholine facilitates the pathogenesis of psoriasis through activating keratinocytes and T cells differentiation via glycolysis.
J Eur Acad Dermatol Venereol;
37(7): 1344-1360, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37013729
19.
Concurrent onset of skin and joint symptoms correlates with higher psoriatic arthritis disease activity: A single-center retrospective study.
J Am Acad Dermatol;
89(1): 173-175, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36889647
20.
Artificial Intelligence-Based Psoriasis Severity Assessment: Real-world Study and Application.
J Med Internet Res;
25: e44932, 2023 03 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36927843